Brief: Sensei Biotherapeutics Posts Qtrly Loss Per Share $0.42
12/05/2021 12:49
May 12 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS FIRST QUARTER 2021 RESULTS
AND
PROVIDES BUSINESS UPDATE
* SENSEI BIOTHERAPEUTICS INC - QTRLY LOSS PER SHARE $0.42
* SENSEI BIOTHERAPEUTICS INC - EXPECTS CURRENT CASH BALANCE
TO
FUND OPERATIONS AT LEAST INTO SECOND HALF OF 2023
Source text for Eikon: ID:nGNX5NdS03
Further company coverage: SNSE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)